In Depth 15 Apr 2024 Does the FDA need to tighten its grip on drug trials in the U.S.? Studies suggest that the FDA has been less rigorous with its drug approval standards. We looked at the current state of the approval process. April 15, 2024 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Expert Advice 5 Apr 2024 How to build a career as an investigator at the FDA? Discover the role and implications of an FDA investigator, a career of high responsibility and challenges, from qualifications to application. April 5, 2024 - 7 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Best in Biotech 28 Mar 2024 Are these T cell receptor (TCR) therapy companies on your radar? As biotechs step up in the TCR therapy space, here are seven companies with promising candidates in the clinic. March 28, 2024 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 27 Mar 2024 Are new treatments for multiple sclerosis on the horizon? As the wait for new multiple sclerosis treatments continue, here are some ongoing clinical trials that hold promise. March 27, 2024 - 10 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 21 Mar 2024 Eight CAR-T cell therapy companies you should know about Discover eight promising biotech companies that are advancing their CAR T cell therapy candidates in the clinic. March 21, 2024 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Podcast 23 Feb 2024Precision neuromedicine: A new dawn for neurological disorders This week on our podcast, explore how precision neuromedicine is reshaping neurological care with Rapport Therapeutics. February 23, 2024 Share WhatsApp Twitter Linkedin Email
In Depth 21 Feb 2024 Cytokine release syndrome: how pharma is tackling a 21st century disease Explore the frontier of biotech’s battle against cytokine release syndrome (CRS), from historical setbacks to cutting-edge solutions. February 21, 2024 - 6 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
In Depth 15 Feb 2024 Turning the tide: recent advancements in childhood cancer research As we observe International Childhood Cancer Day today, let us take a look at some of the recent advancements in childhood cancer research. February 15, 2024 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 12 Feb 2024 RNA editing set to take off: could DNA’s short-lived cousin overcome the limitations of CRISPR gene editing? Find out all about about RNA editing, as two candidates have just managed to reach the clinic for the first time. February 12, 2024 - 7 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 31 Jan 2024 New epilepsy drugs: what is in the pipeline? Find out about the new epilepsy drugs currently in the pipeline, as resistance to current AEDs underscores the need for new treatments. January 31, 2024 - 6 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 26 Jan 2024 Long COVID: are we on the verge of a breakthrough? Studies and recent developments in long COVID research could pave the way for more diagnostic and therapeutic opportunities. January 26, 2024 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 4 Jan 2024 Can GLP-1 agonists, the miraculous obesity drugs, treat cardiovascular diseases? Discover how GLP-1 agonists, known for treating diabetes and obesity, are now being studied for their potential in tackling heart diseases. January 4, 2024 - 6 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email